SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-21-019518
Filing Date
2021-08-12
Accepted
2021-08-12 16:21:17
Documents
78
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1555554
2 ex10-1.htm EX-10.1 45624
3 ex10-2.htm EX-10.2 15644
4 ex10-3.htm EX-10.3 79793
5 ex31-1.htm EX-31.1 17495
6 ex31-2.htm EX-31.2 17503
7 ex32-1.htm EX-32.1 8814
  Complete submission text file 0001493152-21-019518.txt   7913922

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE lctx-20210630.xsd EX-101.SCH 64183
9 XBRL CALCULATION FILE lctx-20210630_cal.xml EX-101.CAL 71592
10 XBRL DEFINITION FILE lctx-20210630_def.xml EX-101.DEF 267988
11 XBRL LABEL FILE lctx-20210630_lab.xml EX-101.LAB 466831
12 XBRL PRESENTATION FILE lctx-20210630_pre.xml EX-101.PRE 368835
13 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 1336721
Mailing Address 2173 SALK AVENUE SUITE 200 CARLSBAD CA 92008
Business Address 2173 SALK AVENUE SUITE 200 CARLSBAD CA 92008 5105213390
Lineage Cell Therapeutics, Inc. (Filer) CIK: 0000876343 (see all company filings)

IRS No.: 943127919 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-12830 | Film No.: 211167876
SIC: 2836 Biological Products, (No Diagnostic Substances)